IL17A and laryngotracheoesophageal cleft: The results of the present meta-analysis revealed that high expression of IL-17 were significantly correlated with a shorter OS and poorer DFS in LC patients, suggesting that increasing expression of IL-17 may be considered as a significant biomarker in predicting the poor clinical outcome of LC.